Tioconazole Production Cost Reports

The report provides a detailed analysis essential for establishing a Tioconazole production plant. It encompasses all critical aspects necessary for Tioconazole production, including the cost of Tioconazole production, Tioconazole plant cost, Tioconazole production costs, and the overall Tioconazole production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Tioconazole production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Tioconazole is an antifungal medication that is used to treat fungal and yeast infections, like vaginal yeast infections. It works by stopping the synthesis of ergosterol (an important component of fungal cell membranes), which disrupts the integrity of the membrane that leads to fungal cell death.

It is available as a topical ointment and is used for conditions like vulvovaginal candidiasis, ringworm, athlete's foot, jock itch, and tinea versicolor. It also has antibacterial effects against certain Gram-positive cocci bacteria. It achieves peak plasma levels of 18 ng/mL in 2-24 hours and relief of symptoms in 24 hours, and full resolution in around 7 days. Its common side effects include mild burning, itching, or irritation.

The Tioconazole market is influenced by the expanding global antifungal drugs market. The rising cases of fungal infection among immunocompromised patients (e.g., cancer, HIV, transplant recipients), diabetes-related vulnerabilities, and antibiotic overuse contribute to its demand.

The increasing demand for azole-class antifungals because of their broad-spectrum efficacy against candidiasis and dermatophytosis boosts their demand. The enhanced OTC availability of topical formulations, along with accessibility in retail and hospital channels, makes it a popular product. The industrial Tioconazole procurement is affected by generic competition and regulatory approvals for innovative short-course topicals. Also, supply chain logistics for stable imidazole APIs and resistance concerns necessitating stockpiling affect its sourcing.

Raw Material for Tioconazole Production

According to the Tioconazole production plant project report, the key raw materials used in the production of Tioconazole include (1-(2,4-Ddichlorophenyl)-2-(1H-Imidazol-1-yl)Ethanol) and(2-Chloro-3-(Chloromethyl)Thiophene).

Production Process of Tioconazole

The extensive Tioconazole production cost report consists of the following major industrial production process:

• By Williamson Ether Synthesis: The production process of Tioconazole involves a Williamson ether synthesis. The process starts by deprotonating 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol (I) with sodium hydride (NaH) in refluxing tetrahydrofuran (THF) to generate the alkoxide. This goes through nucleophilic substitution with 2-chloro-3-(chloromethyl)thiophene (II). This displaces the chloride to form the ether linkage and yield tioconazole.

Tioconazole is a white or off-white crystalline powder with a molecular formula of C16H13Cl3N2OS and a molecular weight of 387.71 g/mol. It shows low water solubility but good solubility in organic solvents like ethanol and acetone. It has a logP of 5.5-6.0, making it highly lipophilic. It has a topological polar surface area of 55.3 Ų, and 6 rotatable bonds contributing to its flexibility. It is stable under airtight storage conditions, features an imidazole ring with trichlorinated thiophene and phenyl groups, enabling binding to fungal 14-α demethylase for ergosterol inhibition. It shows a monoclinic crystal structure. All these physical and chemical properties make it useful in topical antifungal applications.